Immune checkpoint inhibitors for refractory childhood cancers
Lancet Oncol
.
2020 Jan;21(1):14-15.
doi: 10.1016/S1470-2045(19)30777-6.
Epub 2019 Nov 25.
Author
Brigitte C Widemann
1
Affiliation
1
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. Electronic address: widemanb@mail.nih.gov.
PMID:
31780254
DOI:
10.1016/S1470-2045(19)30777-6
No abstract available
Publication types
Comment
MeSH terms
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Child
Hodgkin Disease*
Humans
Lymphoma, Non-Hodgkin*
Young Adult
Substances
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
atezolizumab